A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

PHASE2CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

January 22, 2025

Study Completion Date

July 9, 2025

Conditions
ObesityOverweight and Obesity
Interventions
DRUG

LY3305677

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (29)

11776

North Suffolk Neurology, Port Jefferson Station

14226

Dent Neurologic Institute, Amherst

24541

Spectrum Medical, Inc., Danville

28562

Lucas Research, Inc., New Bern

32003

Northeast Research Institute (NERI), Fleming Island

32162

Charter Research - Lady Lake, The Villages

32803

Charter Research - Winter Park, Orlando

34652

Suncoast Clinical Research, Inc., New Port Richey

37211

Quality Medical Research, Nashville

40213

L-MARC Research Center, Louisville

45212

CTI Clinical Research Center, Cincinnati

60640

Great Lakes Clinical Trials - Andersonville, Chicago

Great Lakes Clinical Trials - Ravenswood, Chicago

63303

StudyMetrix Research, City of Saint Peters

66606

Cotton O'Neil Diabetes & Endocrinology, Topeka

75230

Velocity Clinical Research, Dallas, Dallas

77079

PlanIt Research, PLLC, Houston

78229

Tekton Research - Fredericksburg Road, San Antonio

78745

IMA Clinical Research Austin, Austin

85225

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler

85260

Headlands Research - Scottsdale, Scottsdale

85712

The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson

89128

Las Vegas Medical Research, Las Vegas

90255

Velocity Clinical Research, Huntington Park, Huntington Park

90274

Peninsula Research Associates, Rolling Hills Estates

94598

Diablo Clinical Research, Inc., Walnut Creek

96817

Pacific Diabetes & Endocrine Center, Honolulu

98801

Central Washington Health Services Association d/b/a Confluence Health, Wenatchee

02492

Knownwell, Needham

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT06124807 - A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight | Biotech Hunter | Biotech Hunter